Cargando…
Harnessing Dendritic Cells for Tumor Antigen Presentation
Dendritic cells (DC) are professional antigen presenting cells that are crucial for the induction of anti-tumor T cell responses. As a consequence, research has focused on the harnessing of DCs for therapeutic interventions. Although current strategies employing ex vivo-generated and tumor-antigen l...
Autores principales: | Nierkens, Stefan, Janssen, Edith M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757412/ https://www.ncbi.nlm.nih.gov/pubmed/24212804 http://dx.doi.org/10.3390/cancers3022195 |
Ejemplares similares
-
Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation
por: Spel, Lotte, et al.
Publicado: (2013) -
Cross-Presentation of Cell-Associated Antigens by Mouse Splenic Dendritic Cell Populations
por: Thacker, Robert I., et al.
Publicado: (2012) -
Harnessing dendritic cells in inflammatory skin diseases
por: Chu, Chung-Ching, et al.
Publicado: (2011) -
In Vivo
MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells
por: Bulte, Jeff W. M., et al.
Publicado: (2021) -
Tumor Antigen Cross-Presentation and the Dendritic Cell: Where it All Begins?
por: McDonnell, Alison M., et al.
Publicado: (2010)